Appearance: Clear or white crystalline powder
Odor: No significant odor
Flavor: No significant flavor
Consistency: Fine-coarse powdered crystal
Solubility: Soluble with oils
Composition: 100% hemp extract by weight
Plant Parts Used in Oil: Whole plant
(flowers, leaves, stems, stalks, seeds)
CBG Isolate
What is CBG?
Cannabigerol (CBG) is another cannabinoid known for helping with Anxiety, Chronic Pain, Depression, and Insominia/disturbed sleep. According to a study by PubMed.gov “Most of the samples (n=65; 51.2%) reported use of CBG-predominant products solely for medical purposes (n=46; 36.2% reported use for medical and recreational purposes; n=8; 6.3% reported recreational use only, and n=8 were missing). The most common conditions the complete sample reported using CBG to treat were anxiety (51.2%), chronic pain (40.9%), depression (33.1%), and insomnia/disturbed sleep (30.7%).
Efficacy was highly rated, with the majority reporting their conditions were “very much improved” or “much improved” by CBG. Furthermore, 73.9% claimed superiority of CBG-predominant cannabis over conventional medicines for chronic pain, 80% for depression, 73% for insomnia, and 78.3% for anxiety.
Forty-four percent of CBG-predominant cannabis users reported no adverse events, with 16.5% noting dry mouth, 15% sleepiness, 11.8% increased appetite, and 8.7% dry eyes. Around 84.3% reported no withdrawal symptoms, with sleep difficulties representing the most frequently endorsed withdrawal symptom (endorsed by two respondents).” This clearly outlines the results and what percentage of the subjects reported each effect which helps us further understand how it impacts a random sample of individuals.
CGB has been known as the mother of all cannabinoids due to the fact that it has so many benefits. CBG is also one of the few cannabinoids that bind to both the CB1 and CB2 receptors, which is why some claim it has a greater potential efficacy and further proves it to be the “Mother of all Cannabinoids”.
Unique Pharmacologic Properties of CBG
According to The Pharmacological Case for Cannibgerol, written by Rahul Nachnani, Wesley m. Raup-Knsavage, and Kent E. Vrana: “CBG is more like Δ9-THC at the CB1/CB2 receptors than CBD, but with lower affinity (by 5-27 fold).” This means it has been proven to bind as well as THC, but without the strong psychoactive effects. Making it a better cannabinoid to use in formulations.
Free Ground Shipping on Orders over $100
Free 2nd Day Air Shipping on Orders over $150
Free Next Day Air Shipping on Orders over $250
Free Shipping to Europe on Orders over $550